Abstract
Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study (S5.006)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have